FDA proposes update to 18-year guidance on developing weight loss drugs
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesClinical Trials Regulation GuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)